Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US OptionsDetailed Quotes
PRCT250516P52500
- 1.37
- -0.77-35.98%
15min DelayClose May 2 16:00 ET
2.10High1.37Low
2.10Open2.14Pre Close3 Volume1.15K Open Interest52.50Strike Price547.00Turnover64.25%IV8.07%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry1.37Extrinsic Value100Contract SizeAmericanOptions Type-0.2874Delta0.0522Gamma44.50Leverage Ratio-0.0909Theta-0.0054Rho-12.79Eff Leverage0.0347Vega
PROCEPT BioRobotics Newsroom
PROCEPT BioRobotics | 10-Q: Q1 2025 Earnings Report
Jefferies Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Intuitive Surgical (ISRG) and Bio-Rad Laboratories (BIO)
PROCEPT BioRobotics to Attend Four Upcoming Investor Conferences in May & June
Earnings Release: Here's Why Analysts Cut Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$77.00
Buy Rating for PROCEPT BioRobotics: Promising Growth in Cancer Treatment Market and BPH Advancements
TD Cowen Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $85
B of A Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $84
PROCEPT BioRobotics Analyst Ratings
PROCEPT BioRobotics (PRCT) Gets a Hold From BTIG
Express News | Procept Biorobotics Corp : BofA Global Research Cuts Price Objective to $84 From $104
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2025 Earnings Conference
PROCEPT BioRobotics Shares Are Trading Lower. The Company Reported Q1 Financial Results.
Express News | PROCEPT BioRobotics Shares Are Trading Lower. The Company Reported Q1 Financial Results
Morgan Stanley Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $95
William Blair Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating
Procept BioRobotics Q1 Net Loss Narrows, Revenue Increases
Positive Outlook for PROCEPT BioRobotics: Strong Sales and Growth Justify Buy Rating
$PRCT Earnings Results: $PRCT Reports Quarterly Earnings
Procept BioRobotics Sees FY25 Revenue $323M, Consensus $321.67M
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
